Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$250,554
-$205,521 QoQ
Shares Held
15,778
-59.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#519
of 1,016 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $124,492,646 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
188,515 | $102,143,081 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
345,899 | $11,719,058 | |
| 3 | ALKS |
Alkermes plc.
|
120,243 | $6,300,733 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
24,037 | $4,051,195 | |
| 5 | VTRS |
Viatris Inc
This page
|
15,778 | $250,554 | |
| 6 | ZTS |
Zoetis Inc.
|
390 | $28,025 |
All Filings in VTRS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,554 | 15,778 | Shares | Defined | 2026-08-14 | |
| 2024-09-30 | $456,075 | 39,283 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $282,024 | 26,531 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $173,309 | 14,515 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $194,972 | 18,003 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,743,721 | 176,848 | Shares | Defined | 2023-11-14 | |
| 2020-12-31 | $171,827 | 9,169 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||